 | • レポートコード：QYR2104Z4676 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、POC感染症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（インフルエンザ、アデノウイルス、マラリア、連鎖球菌性細菌血症、結核（TB）、潜血、HIV）、用途別市場規模（病院＆診療所、臨床診断研究所、在宅医療設置）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・POC感染症の市場動向 ・企業の競争状況、市場シェア ・POC感染症の種類別市場規模（インフルエンザ、アデノウイルス、マラリア、連鎖球菌性細菌血症、結核（TB）、潜血、HIV） ・POC感染症の用途別市場規模（病院＆診療所、臨床診断研究所、在宅医療設置） ・POC感染症の北米市場規模2016-2027（アメリカ、カナダ） ・POC感染症のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・POC感染症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・POC感染症の中南米市場規模2016-2027（メキシコ、ブラジル） ・POC感染症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Meridian Bioscience、Orasure Technologies、Trinity Biotech、Abbott、Beckman Coulter/ Danaher、Becton Dickinson、Biomerieux、Bio-Rad、Cepheid、Diamedix、Diasorin、Eiken Chemical、Enzo Biochem） ・結論 |
POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care.
Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted period.
Market Analysis and Insights: Global POC Infectious Diseases Market
The global POC Infectious Diseases market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global POC Infectious Diseases market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global POC Infectious Diseases market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global POC Infectious Diseases market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global POC Infectious Diseases market.
Global POC Infectious Diseases Scope and Market Size
POC Infectious Diseases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global POC Infectious Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Flu
Adenovirus
Malaria
Streptococcal Bacteremia
Tuberculosis (TB)
Occult Blood
HIV
Segment by Application
Hospital& Clinics
Clinical Diagnostic Laboratories
Homecare Settings
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Meridian Bioscience
Orasure Technologies
Trinity Biotech
Abbott
Beckman Coulter/ Danaher
Becton Dickinson
Biomerieux
Bio-Rad
Trinity Biotech
Abbott
Diasorin
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global POC Infectious Diseases Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Flu
1.2.3 Adenovirus
1.2.4 Malaria
1.2.5 Streptococcal Bacteremia
1.2.6 Tuberculosis (TB)
1.2.7 Occult Blood
1.2.8 HIV
1.3 Market by Application
1.3.1 Global POC Infectious Diseases Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital& Clinics
1.3.3 Clinical Diagnostic Laboratories
1.3.4 Homecare Settings
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global POC Infectious Diseases Market Perspective (2016-2027)
2.2 POC Infectious Diseases Growth Trends by Regions
2.2.1 POC Infectious Diseases Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 POC Infectious Diseases Historic Market Share by Regions (2016-2021)
2.2.3 POC Infectious Diseases Forecasted Market Size by Regions (2022-2027)
2.3 POC Infectious Diseases Industry Dynamic
2.3.1 POC Infectious Diseases Market Trends
2.3.2 POC Infectious Diseases Market Drivers
2.3.3 POC Infectious Diseases Market Challenges
2.3.4 POC Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top POC Infectious Diseases Players by Revenue
3.1.1 Global Top POC Infectious Diseases Players by Revenue (2016-2021)
3.1.2 Global POC Infectious Diseases Revenue Market Share by Players (2016-2021)
3.2 Global POC Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by POC Infectious Diseases Revenue
3.4 Global POC Infectious Diseases Market Concentration Ratio
3.4.1 Global POC Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by POC Infectious Diseases Revenue in 2020
3.5 POC Infectious Diseases Key Players Head office and Area Served
3.6 Key Players POC Infectious Diseases Product Solution and Service
3.7 Date of Enter into POC Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 POC Infectious Diseases Breakdown Data by Type
4.1 Global POC Infectious Diseases Historic Market Size by Type (2016-2021)
4.2 Global POC Infectious Diseases Forecasted Market Size by Type (2022-2027)
5 POC Infectious Diseases Breakdown Data by Application
5.1 Global POC Infectious Diseases Historic Market Size by Application (2016-2021)
5.2 Global POC Infectious Diseases Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America POC Infectious Diseases Market Size (2016-2027)
6.2 North America POC Infectious Diseases Market Size by Type
6.2.1 North America POC Infectious Diseases Market Size by Type (2016-2021)
6.2.2 North America POC Infectious Diseases Market Size by Type (2022-2027)
6.2.3 North America POC Infectious Diseases Market Size by Type (2016-2027)
6.3 North America POC Infectious Diseases Market Size by Application
6.3.1 North America POC Infectious Diseases Market Size by Application (2016-2021)
6.3.2 North America POC Infectious Diseases Market Size by Application (2022-2027)
6.3.3 North America POC Infectious Diseases Market Size by Application (2016-2027)
6.4 North America POC Infectious Diseases Market Size by Country
6.4.1 North America POC Infectious Diseases Market Size by Country (2016-2021)
6.4.2 North America POC Infectious Diseases Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe POC Infectious Diseases Market Size (2016-2027)
7.2 Europe POC Infectious Diseases Market Size by Type
7.2.1 Europe POC Infectious Diseases Market Size by Type (2016-2021)
7.2.2 Europe POC Infectious Diseases Market Size by Type (2022-2027)
7.2.3 Europe POC Infectious Diseases Market Size by Type (2016-2027)
7.3 Europe POC Infectious Diseases Market Size by Application
7.3.1 Europe POC Infectious Diseases Market Size by Application (2016-2021)
7.3.2 Europe POC Infectious Diseases Market Size by Application (2022-2027)
7.3.3 Europe POC Infectious Diseases Market Size by Application (2016-2027)
7.4 Europe POC Infectious Diseases Market Size by Country
7.4.1 Europe POC Infectious Diseases Market Size by Country (2016-2021)
7.4.2 Europe POC Infectious Diseases Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific POC Infectious Diseases Market Size (2016-2027)
8.2 Asia-Pacific POC Infectious Diseases Market Size by Type
8.2.1 Asia-Pacific POC Infectious Diseases Market Size by Type (2016-2021)
8.2.2 Asia-Pacific POC Infectious Diseases Market Size by Type (2022-2027)
8.2.3 Asia-Pacific POC Infectious Diseases Market Size by Type (2016-2027)
8.3 Asia-Pacific POC Infectious Diseases Market Size by Application
8.3.1 Asia-Pacific POC Infectious Diseases Market Size by Application (2016-2021)
8.3.2 Asia-Pacific POC Infectious Diseases Market Size by Application (2022-2027)
8.3.3 Asia-Pacific POC Infectious Diseases Market Size by Application (2016-2027)
8.4 Asia-Pacific POC Infectious Diseases Market Size by Region
8.4.1 Asia-Pacific POC Infectious Diseases Market Size by Region (2016-2021)
8.4.2 Asia-Pacific POC Infectious Diseases Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America POC Infectious Diseases Market Size (2016-2027)
9.2 Latin America POC Infectious Diseases Market Size by Type
9.2.1 Latin America POC Infectious Diseases Market Size by Type (2016-2021)
9.2.2 Latin America POC Infectious Diseases Market Size by Type (2022-2027)
9.2.3 Latin America POC Infectious Diseases Market Size by Type (2016-2027)
9.3 Latin America POC Infectious Diseases Market Size by Application
9.3.1 Latin America POC Infectious Diseases Market Size by Application (2016-2021)
9.3.2 Latin America POC Infectious Diseases Market Size by Application (2022-2027)
9.3.3 Latin America POC Infectious Diseases Market Size by Application (2016-2027)
9.4 Latin America POC Infectious Diseases Market Size by Country
9.4.1 Latin America POC Infectious Diseases Market Size by Country (2016-2021)
9.4.2 Latin America POC Infectious Diseases Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa POC Infectious Diseases Market Size (2016-2027)
10.2 Middle East & Africa POC Infectious Diseases Market Size by Type
10.2.1 Middle East & Africa POC Infectious Diseases Market Size by Type (2016-2021)
10.2.2 Middle East & Africa POC Infectious Diseases Market Size by Type (2022-2027)
10.2.3 Middle East & Africa POC Infectious Diseases Market Size by Type (2016-2027)
10.3 Middle East & Africa POC Infectious Diseases Market Size by Application
10.3.1 Middle East & Africa POC Infectious Diseases Market Size by Application (2016-2021)
10.3.2 Middle East & Africa POC Infectious Diseases Market Size by Application (2022-2027)
10.3.3 Middle East & Africa POC Infectious Diseases Market Size by Application (2016-2027)
10.4 Middle East & Africa POC Infectious Diseases Market Size by Country
10.4.1 Middle East & Africa POC Infectious Diseases Market Size by Country (2016-2021)
10.4.2 Middle East & Africa POC Infectious Diseases Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott POC Infectious Diseases Introduction
11.1.4 Abbott Revenue in POC Infectious Diseases Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Meridian Bioscience
11.2.1 Meridian Bioscience Company Details
11.2.2 Meridian Bioscience Business Overview
11.2.3 Meridian Bioscience POC Infectious Diseases Introduction
11.2.4 Meridian Bioscience Revenue in POC Infectious Diseases Business (2016-2021)
11.2.5 Meridian Bioscience Recent Development
11.3 Orasure Technologies
11.3.1 Orasure Technologies Company Details
11.3.2 Orasure Technologies Business Overview
11.3.3 Orasure Technologies POC Infectious Diseases Introduction
11.3.4 Orasure Technologies Revenue in POC Infectious Diseases Business (2016-2021)
11.3.5 Orasure Technologies Recent Development
11.4 Trinity Biotech
11.4.1 Trinity Biotech Company Details
11.4.2 Trinity Biotech Business Overview
11.4.3 Trinity Biotech POC Infectious Diseases Introduction
11.4.4 Trinity Biotech Revenue in POC Infectious Diseases Business (2016-2021)
11.4.5 Trinity Biotech Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott POC Infectious Diseases Introduction
11.5.4 Abbott Revenue in POC Infectious Diseases Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 Beckman Coulter/ Danaher
11.6.1 Beckman Coulter/ Danaher Company Details
11.6.2 Beckman Coulter/ Danaher Business Overview
11.6.3 Beckman Coulter/ Danaher POC Infectious Diseases Introduction
11.6.4 Beckman Coulter/ Danaher Revenue in POC Infectious Diseases Business (2016-2021)
11.6.5 Beckman Coulter/ Danaher Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Details
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson POC Infectious Diseases Introduction
11.7.4 Becton Dickinson Revenue in POC Infectious Diseases Business (2016-2021)
11.7.5 Becton Dickinson Recent Development
11.8 Biomerieux
11.8.1 Biomerieux Company Details
11.8.2 Biomerieux Business Overview
11.8.3 Biomerieux POC Infectious Diseases Introduction
11.8.4 Biomerieux Revenue in POC Infectious Diseases Business (2016-2021)
11.8.5 Biomerieux Recent Development
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad POC Infectious Diseases Introduction
11.9.4 Bio-Rad Revenue in POC Infectious Diseases Business (2016-2021)
11.9.5 Bio-Rad Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Details
11.10.2 Cepheid Business Overview
11.10.3 Cepheid POC Infectious Diseases Introduction
11.10.4 Cepheid Revenue in POC Infectious Diseases Business (2016-2021)
11.10.5 Cepheid Recent Development
11.11 Diamedix
11.11.1 Diamedix Company Details
11.11.2 Diamedix Business Overview
11.11.3 Diamedix POC Infectious Diseases Introduction
11.11.4 Diamedix Revenue in POC Infectious Diseases Business (2016-2021)
11.11.5 Diamedix Recent Development
11.12 Diasorin
11.12.1 Diasorin Company Details
11.12.2 Diasorin Business Overview
11.12.3 Diasorin POC Infectious Diseases Introduction
11.12.4 Diasorin Revenue in POC Infectious Diseases Business (2016-2021)
11.12.5 Diasorin Recent Development
11.13 Eiken Chemical
11.13.1 Eiken Chemical Company Details
11.13.2 Eiken Chemical Business Overview
11.13.3 Eiken Chemical POC Infectious Diseases Introduction
11.13.4 Eiken Chemical Revenue in POC Infectious Diseases Business (2016-2021)
11.13.5 Eiken Chemical Recent Development
11.14 Enzo Biochem
11.14.1 Enzo Biochem Company Details
11.14.2 Enzo Biochem Business Overview
11.14.3 Enzo Biochem POC Infectious Diseases Introduction
11.14.4 Enzo Biochem Revenue in POC Infectious Diseases Business (2016-2021)
11.14.5 Enzo Biochem Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global POC Infectious Diseases Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Flu
Table 3. Key Players of Adenovirus
Table 4. Key Players of Malaria
Table 5. Key Players of Streptococcal Bacteremia
Table 6. Key Players of Tuberculosis (TB)
Table 7. Key Players of Occult Blood
Table 8. Key Players of HIV
Table 9. Global POC Infectious Diseases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global POC Infectious Diseases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global POC Infectious Diseases Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global POC Infectious Diseases Market Share by Regions (2016-2021)
Table 13. Global POC Infectious Diseases Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global POC Infectious Diseases Market Share by Regions (2022-2027)
Table 15. POC Infectious Diseases Market Trends
Table 16. POC Infectious Diseases Market Drivers
Table 17. POC Infectious Diseases Market Challenges
Table 18. POC Infectious Diseases Market Restraints
Table 19. Global POC Infectious Diseases Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global POC Infectious Diseases Market Share by Players (2016-2021)
Table 21. Global Top POC Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in POC Infectious Diseases as of 2020)
Table 22. Ranking of Global Top POC Infectious Diseases Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by POC Infectious Diseases Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players POC Infectious Diseases Product Solution and Service
Table 26. Date of Enter into POC Infectious Diseases Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global POC Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 29. Global POC Infectious Diseases Revenue Market Share by Type (2016-2021)
Table 30. Global POC Infectious Diseases Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global POC Infectious Diseases Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global POC Infectious Diseases Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global POC Infectious Diseases Revenue Market Share by Application (2016-2021)
Table 34. Global POC Infectious Diseases Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global POC Infectious Diseases Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America POC Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 37. North America POC Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America POC Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 39. North America POC Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America POC Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America POC Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe POC Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe POC Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe POC Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe POC Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe POC Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe POC Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific POC Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific POC Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific POC Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific POC Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific POC Infectious Diseases Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific POC Infectious Diseases Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America POC Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America POC Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America POC Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America POC Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America POC Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America POC Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa POC Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa POC Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa POC Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa POC Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa POC Infectious Diseases Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa POC Infectious Diseases Market Size by Country (2022-2027) & (US$ Million)
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott POC Infectious Diseases Product
Table 69. Abbott Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Meridian Bioscience Company Details
Table 72. Meridian Bioscience Business Overview
Table 73. Meridian Bioscience POC Infectious Diseases Product
Table 74. Meridian Bioscience Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 75. Meridian Bioscience Recent Development
Table 76. Orasure Technologies Company Details
Table 77. Orasure Technologies Business Overview
Table 78. Orasure Technologies POC Infectious Diseases Product
Table 79. Orasure Technologies Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 80. Orasure Technologies Recent Development
Table 81. Trinity Biotech Company Details
Table 82. Trinity Biotech Business Overview
Table 83. Trinity Biotech POC Infectious Diseases Product
Table 84. Trinity Biotech Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 85. Trinity Biotech Recent Development
Table 86. Abbott Company Details
Table 87. Abbott Business Overview
Table 88. Abbott POC Infectious Diseases Product
Table 89. Abbott Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 90. Abbott Recent Development
Table 91. Beckman Coulter/ Danaher Company Details
Table 92. Beckman Coulter/ Danaher Business Overview
Table 93. Beckman Coulter/ Danaher POC Infectious Diseases Product
Table 94. Beckman Coulter/ Danaher Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 95. Beckman Coulter/ Danaher Recent Development
Table 96. Becton Dickinson Company Details
Table 97. Becton Dickinson Business Overview
Table 98. Becton Dickinson POC Infectious Diseases Product
Table 99. Becton Dickinson Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 100. Becton Dickinson Recent Development
Table 101. Biomerieux Company Details
Table 102. Biomerieux Business Overview
Table 103. Biomerieux Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 104. Biomerieux Recent Development
Table 105. Bio-Rad Company Details
Table 106. Bio-Rad Business Overview
Table 107. Bio-Rad POC Infectious Diseases Product
Table 108. Bio-Rad Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 109. Bio-Rad Recent Development
Table 110. Cepheid Company Details
Table 111. Cepheid Business Overview
Table 112. Cepheid POC Infectious Diseases Product
Table 113. Cepheid Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 114. Cepheid Recent Development
Table 115. Diamedix Company Details
Table 116. Diamedix Business Overview
Table 117. Diamedix POC Infectious Diseases Product
Table 118. Diamedix Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 119. Diamedix Recent Development
Table 120. Diasorin Company Details
Table 121. Diasorin Business Overview
Table 122. Diasorin POC Infectious Diseases Product
Table 123. Diasorin Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 124. Diasorin Recent Development
Table 125. Eiken Chemical Company Details
Table 126. Eiken Chemical Business Overview
Table 127. Eiken Chemical POC Infectious Diseases Product
Table 128. Eiken Chemical Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 129. Eiken Chemical Recent Development
Table 130. Enzo Biochem Company Details
Table 131. Enzo Biochem Business Overview
Table 132. Enzo Biochem POC Infectious Diseases Product
Table 133. Enzo Biochem Revenue in POC Infectious Diseases Business (2016-2021) & (US$ Million)
Table 134. Enzo Biochem Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global POC Infectious Diseases Market Share by Type: 2020 VS 2027
Figure 2. Flu Features
Figure 3. Adenovirus Features
Figure 4. Malaria Features
Figure 5. Streptococcal Bacteremia Features
Figure 6. Tuberculosis (TB) Features
Figure 7. Occult Blood Features
Figure 8. HIV Features
Figure 9. Global POC Infectious Diseases Market Share by Application: 2020 VS 2027
Figure 10. Hospital& Clinics Case Studies
Figure 11. Clinical Diagnostic Laboratories Case Studies
Figure 12. Homecare Settings Case Studies
Figure 13. POC Infectious Diseases Report Years Considered
Figure 14. Global POC Infectious Diseases Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global POC Infectious Diseases Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global POC Infectious Diseases Market Share by Regions: 2020 VS 2027
Figure 17. Global POC Infectious Diseases Market Share by Regions (2022-2027)
Figure 18. Global POC Infectious Diseases Market Share by Players in 2020
Figure 19. Global Top POC Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in POC Infectious Diseases as of 2020
Figure 20. The Top 10 and 5 Players Market Share by POC Infectious Diseases Revenue in 2020
Figure 21. Global POC Infectious Diseases Revenue Market Share by Type (2016-2021)
Figure 22. Global POC Infectious Diseases Revenue Market Share by Type (2022-2027)
Figure 23. North America POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America POC Infectious Diseases Market Share by Type (2016-2027)
Figure 25. North America POC Infectious Diseases Market Share by Application (2016-2027)
Figure 26. North America POC Infectious Diseases Market Share by Country (2016-2027)
Figure 27. United States POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe POC Infectious Diseases Market Share by Type (2016-2027)
Figure 31. Europe POC Infectious Diseases Market Share by Application (2016-2027)
Figure 32. Europe POC Infectious Diseases Market Share by Country (2016-2027)
Figure 33. Germany POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific POC Infectious Diseases Market Share by Type (2016-2027)
Figure 41. Asia-Pacific POC Infectious Diseases Market Share by Application (2016-2027)
Figure 42. Asia-Pacific POC Infectious Diseases Market Share by Region (2016-2027)
Figure 43. China POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America POC Infectious Diseases Market Share by Type (2016-2027)
Figure 51. Latin America POC Infectious Diseases Market Share by Application (2016-2027)
Figure 52. Latin America POC Infectious Diseases Market Share by Country (2016-2027)
Figure 53. Mexico POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa POC Infectious Diseases Market Share by Type (2016-2027)
Figure 57. Middle East & Africa POC Infectious Diseases Market Share by Application (2016-2027)
Figure 58. Middle East & Africa POC Infectious Diseases Market Share by Country (2016-2027)
Figure 59. Turkey POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE POC Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Abbott Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 63. Meridian Bioscience Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 64. Orasure Technologies Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 65. Trinity Biotech Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 66. Abbott Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 67. Beckman Coulter/ Danaher Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 68. Becton Dickinson Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 69. Biomerieux Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 70. Bio-Rad Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 71. Cepheid Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 72. Diamedix Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 73. Diasorin Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 74. Eiken Chemical Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 75. Enzo Biochem Revenue Growth Rate in POC Infectious Diseases Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の感染症市場規模・現状・予測（2021年-2027年） When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antip…- 世界の感染症検査・診断市場規模・現状・予測（2021年-2027年） Infectious disease testing is the process of identification of causative organisms for the primary diagnosis of diseases. Market Analysis and Insights: Global Infectious Disease Testing And Diagnostic Market The global Infectious Disease Testing And Diagnostic market size is projected to reach US$ X…
- 世界の感染症検査・診断市場規模・現状・予測（2021年-2027年） Infectious disease testing is the process of identification of causative organisms for the primary diagnosis of diseases. Market Analysis and Insights: Global Infectious Disease Testing And Diagnostic Market The global Infectious Disease Testing And Diagnostic market size is projected to reach US$ X…
- 世界の感染免疫学市場 2021：企業別、地域別、種類・用途別 The Infectious Immunology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の呼吸器疾患診断検査市場規模・現状・予測（2021年-2027年） Respiratory Diseases Diagnostic Testing is the procedure to test if the patient have the Respiratory Diseases Market Analysis and Insights: Global Respiratory Diseases Diagnostic Testing Market The global Respiratory Diseases Diagnostic Testing market size is projected to reach US$ XX million by 202…